Abstract
A patient with AMI caused by a large thrombus in the proximal LAD was successfully treated with PTCA and an intracoronary lysis combined with the platelet-receptor antagonist c7E3. Analysis of cellular hemostasis after 1 and 6 months revealed a sustained platelet activation despite combined anti-platelet therapy with ASA and ticlopidine. A progredient slow-flow phenomenon appeared during control angiographies, confirmed by intracoronary Doppler examination.
MeSH terms
-
Abciximab
-
Adult
-
Angioplasty, Balloon, Coronary
-
Antibodies, Monoclonal / therapeutic use
-
Blood Coagulation / drug effects
-
Blood Flow Velocity
-
Coronary Angiography*
-
Coronary Circulation* / drug effects
-
Coronary Thrombosis / complications
-
Coronary Thrombosis / diagnosis*
-
Coronary Thrombosis / physiopathology
-
Coronary Thrombosis / therapy
-
Flow Cytometry
-
Follow-Up Studies
-
Humans
-
Immunoglobulin Fab Fragments / therapeutic use
-
Male
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / etiology
-
Myocardial Infarction / therapy
-
Platelet Activation* / drug effects
-
Platelet Aggregation Inhibitors / therapeutic use
-
Thrombolytic Therapy
-
Ultrasonography, Interventional*
-
Vascular Patency
Substances
-
Antibodies, Monoclonal
-
Immunoglobulin Fab Fragments
-
Platelet Aggregation Inhibitors
-
Abciximab